Through joint collaborations with top pharmaceutical companies and research institutions, KREX has been used to identify autoantibody biomarkers for commercial diagnostics and screening applications. In addition, KREX has also been used to identify biologics with therapeutics potential.
1996 – 2019 © Sengenics All rights reserved | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D | Sengenics UK Ltd. Registered in England and Wales No 11016361
1996 – 2019 © Sengenics All rights reserved